Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

Colgate-Palmolive executive sells over $579k in company stock

Published 03/05/2024, 21:08
CL
-

In a recent transaction on May 1, John P. Bilbrey, a director at Colgate-Palmolive Co. (NYSE:CL), sold 6,329 shares of the company's common stock, resulting in a total sale value of over $579,695. The shares were sold at an average price of $91.59. On the same day, Bilbrey also exercised options to acquire the same number of shares at a price of $62.04, which amounted to a total transaction value of approximately $392,651.

The transactions were part of the executive's stock option exercise and subsequent sale, with part of the proceeds being used to cover the exercise price of the options, as detailed in the footnotes of the SEC filing. The options were part of an incentive compensation plan and became exercisable in one-third increments after the first anniversary of their grant date, which was on May 14, 2018.

Following these transactions, Bilbrey's direct holdings in Colgate-Palmolive decreased to 30,236 common stock shares. Additionally, the report disclosed indirect ownership of 4,719 common stock shares held by a trust.

Investors often monitor insider transactions such as these for insights into executive sentiment toward their company's stock. Colgate-Palmolive, known for its consumer products including oral care, personal care, and home care products, has its shares publicly traded and is followed by investors seeking to understand the actions of its executives.

The filing was signed on behalf of John P. Bilbrey by Kristine Hutchinson, Attorney-in-Fact, and was submitted on May 3, as per the SEC documentation.

InvestingPro Insights

As investors scrutinize the recent insider transactions within Colgate-Palmolive Co. (NYSE:CL), they may also find it valuable to consider the company's broader financial landscape and performance metrics. According to InvestingPro data, Colgate-Palmolive boasts a market capitalization of $76.2 billion, reflecting its significant presence in the consumer goods sector. The company's Price/Earnings (P/E) ratio stands at 28.43 on a last twelve months basis as of Q1 2024, which suggests a valuation that investors may weigh against the company's earnings growth prospects.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

One notable InvestingPro Tip for Colgate-Palmolive is its impressive gross profit margin, which was reported at 59.0% for the same period. This indicates the company's ability to maintain a strong profitability ratio in the production of its goods, a factor that could be reassuring for investors considering the stock's fundamentals. Additionally, Colgate-Palmolive's dividend yield is 2.15%, with the company having raised its dividend for 54 consecutive years, underscoring a commitment to returning value to shareholders.

Investors looking for more insights into Colgate-Palmolive's financial health and stock performance can find additional InvestingPro Tips, including an analysis of the stock's low price volatility and its ability to cover interest payments with cash flows. There are 11 more tips available, offering a deeper dive into the company's valuation and market position. For those interested in further analysis and tips, visit https://www.investing.com/pro/CL and remember to use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.